Chemoinformaics analysis of 2-[5-(2-Hydroxy-propyl)-tetrahydrofuran-2-yl]-propionic acid, t-butyl ester
Molecular Weight | 258.358 | nRot | 4 |
Heavy Atom Molecular Weight | 232.15 | nRig | 6 |
Exact Molecular Weight | 258.183 | nRing | 1 |
Solubility: LogS | -2.207 | nHRing | 1 |
Solubility: LogP | 2.068 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 43.9246 |
nHD | 1 | BPOL | 30.4234 |
QED | 0.786 |
Synth | 3.814 |
Natural Product Likeliness | 1.58 |
NR-PPAR-gamma | 0.283 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.017 |
Pgp-sub | 0.006 |
HIA | 0.002 |
CACO-2 | -4.513 |
MDCK | 0.000085 |
BBB | 0.679 |
PPB | 0.630198 |
VDSS | 1.529 |
FU | 0.460252 |
CYP1A2-inh | 0.028 |
CYP1A2-sub | 0.29 |
CYP2c19-inh | 0.035 |
CYP2c19-sub | 0.906 |
CYP2c9-inh | 0.012 |
CYP2c9-sub | 0.15 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.252 |
CYP3a4-inh | 0.016 |
CYP3a4-sub | 0.479 |
CL | 12.401 |
T12 | 0.483 |
hERG | 0.008 |
Ames | 0.07 |
ROA | 0.018 |
SkinSen | 0.103 |
Carcinogencity | 0.891 |
EI | 0.862 |
Respiratory | 0.029 |
NR-Aromatase | 0.012 |
Antiviral | Yes |
Prediction | 0.753013 |